Pérez-Martelo, Martín
González-García, Alejandro
Vidal-Ínsua, Yolanda
Blanco-Freire, Cristina
Brozos-Vázquez, Elena María
Abdulkader-Nallib, Ihab
Álvarez-Fernández, Javier
Lázare-Iglesias, Héctor
García-Martínez, Carolina
Betancor, Yoel Z.
Sánchez-Ares, María
Tubío, Jose M. C.
Vázquez-Rivera, Francisca
Candamio-Folgar, Sonia
López-López, Rafael
Ruiz-Bañobre, Juan
Funding for this research was provided by:
Fundación Merck Salud (2015 Merck Serono Research Grant)
Spanish Cooperative Group for the Treatment of Digestive Tumors (2020 TTD Research Grant)
Article History
Received: 12 November 2021
Accepted: 18 March 2022
First Online: 27 April 2022
Competing interests
: Martín Pérez-Martelo—Travel, accommodations, expenses: Leo Pharma, Daiichi Sankyo, Pfizer, Pierre Fabre. Yolanda Vidal-Ínsua—Honoraria for consultancies: PharmaMar. Elena Brozos-Vázquez—Travel, accommodations, expenses: Merck, Sanofi, Roche, Pierre Fabre, and Amgen; honoraria for consultancies: Leo Pharma, and Rovi. Javier Álvarez-Fernández—Travel, accommodations, expenses: Pfizer, Bristol-Myers Squibb, Janssen, Roche, PharmaMar; honoraria for consultancies: Pfizer. Francisca Vázquez-Rivera—Travel, accommodations, expenses: Lilly, Merck, Pierre Fabre; honoraria for consultancies: Roche, Servier. Sonia Candamio-Folgar—Travel, accommodations, expenses: Lilly, Merck; honoraria for educational activities: Servier. Rafael López-López—Travel, accommodations, expenses: Lilly, Novartis, Pfizer, Merck, Roche, and Bristol-Myers Squibb; honoraria for educational activities: Lilly, Novartis, Pfizer, Merck, Roche, and Bristol-Myers Squibb; honoraria for consultancies: Pharmamar, Bayer, and Pierre Fabre. Juan Ruiz-Bañobre—Travel, accommodations, expenses: Bristol-Myers Squibb, Merck Sharp & Dohme, Ipsen, PharmaMar, Pfizer and Roche; honoraria for educational activities: Roche; honoraria for consultancies: Boehringer Ingelheim; institutional research funding: Roche. The other authors have no conflicts of interest to declare.